2024 annual financial data
Biodexa Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -9,199,000 GBP and net income was -5,729,000 GBP.
Operating cash flow was -12,261,000 GBP.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 GBP
- Operating income
- -9,199,000 GBP
- Net income
- -5,729,000 GBP
- Operating cash flow
- -12,261,000 GBP